Inovio Pharmaceuticals (NSDQ:INO) shares took a hit this morning on second-quarter results that missed the consensus forecast.
INO shares were down -4.7% at $9.15 per share before the market opened today.
Get the full story at our sister site, Drug Delivery Business News.